La Vie Health Care Limited v NHS England (South East London Integrated Care Board)

Facts

La Vie Health Care Limited, whose director is Mr Chinedu Ahamefula and whose Superintendent Pharmacist is Ms Eberechukwa Nwokocha-Ahaaiwe, had from about 2013 provided NHS pharmaceutical services as Grove Pharmacy in Charlton, and was included in the pharmaceutical list for the London Borough of Greenwich. In July 2022 the company says its landlord shut the premises and forcibly evicted it, sealing in its documents and stock, so the business sought to relocate to Mottingham. A relocation application made on 5 March 2024 was met with the response that the new premises fell within the Bromley Health and Wellbeing Board area, so that fitness information was required; a second application on 19 July 2024 was rejected, and a third was made on 16 December 2024, in which the applicant ticked the box confirming that fitness information had already been supplied, in February 2013, and remained accurate. Asked to complete a fresh fitness form, Ms Nwokocha-Ahaaiwe answered "no" to whether she had been subject to any fitness to practise investigation, though the General Pharmaceutical Council told the respondent she had been warned by its Investigating Committee on 4 April 2018 over a pharmacy operating without adequate indemnity insurance. On 6 February 2026 the South-East London Integrated Care Board refused inclusion in the Bromley pharmaceutical list under regulation 33(2) of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013. La Vie appealed.